Skip to main content
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Browse by collection
Archive
Authors
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Browse by collection
Archive
Authors
About
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Archive
Volume 11, Issue Suppl 1
720 A phase 1/2 study of BDC-3042, a novel Dectin-2 agonistic antibody, in patients with advanced cancers
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
PDF
Regular and Young Investigator Award Abstracts
Clinical Trial In Progress
720 A phase 1/2 study of BDC-3042, a novel Dectin-2 agonistic antibody, in patients with advanced cancers
Online download statistics by month:
Online download statistics by month: November 2023 to June 2025
Abstract
Full
Pdf
Nov 2023
180
0
13
Dec 2023
76
0
7
Jan 2024
77
0
6
Feb 2024
62
0
2
Mar 2024
76
0
3
Apr 2024
68
0
5
May 2024
104
0
16
Jun 2024
68
0
2
Jul 2024
64
0
4
Aug 2024
80
0
5
Sep 2024
44
0
4
Oct 2024
42
0
6
Nov 2024
106
0
15
Dec 2024
66
0
18
Jan 2025
77
0
11
Feb 2025
31
0
4
Mar 2025
0
0
7
Apr 2025
0
0
4
May 2025
0
0
3
Jun 2025
0
0
3
Total
1221
0
138
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
PDF